Skip Navigation

A Phase IB and Randomized Phase II Trial of Megestrol Acetate With or Without Ipatasertib in Recurrent or Metastatic Endometrioid Endometrial Cancer

Brief Summary

Type:
Endometrial

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT05538897

Study #:
STUDY00160661

Start Date:
Jun 27, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05538897

View Complete Trial Details & Eligibility at ClinicalTrials.gov